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during the 2009/10 pandemic.
Methods.Weanalysed data from ﬁve national telephone surveys conducted in the UK during the latter stages
of the pandemic to identify predictors of uptake amongst members of the public offered the vaccine by their pri-
mary care physician (n=1320). In addition to demographic variables, participants reported: reasons for declin-
ing the vaccination, levels of worry about the risk of catching swine ﬂu, whether too much fuss was being made
about the pandemic, whether they or a close friend or relative had had swine ﬂu, how effective they felt the vac-
cine was, whether they had previously had a seasonal ﬂu vaccination, how well prepared they felt the govern-
ment was for a pandemic and how satisﬁed they were with information available about the pandemic. Most
participants (n= 734, 55.6%) reported being vaccinated against swine ﬂu, compared to 396 who had not been
vaccinated and were unlikely to be vaccinated in the future.
Results. The main reasons given for declining vaccination were concerns over the vaccine's safety, and being
generally healthy. Controlling for demographic variables, risk factors for not being vaccinatedwere: being female,
not having a long-standing inﬁrmity or illness, not having been vaccinated against seasonal ﬂu in previous years,
feeling that too much fuss had been made about the pandemic and believing that the vaccine was ineffective.
Conclusions. Interventions that target these factorsmay be effective in improving uptake in a future pandemic.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
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During the latter stages of the 2009/10 inﬂuenza A H1N1v (“swine
ﬂu”) pandemic, many governments offered the newly developed
swine ﬂu vaccine to members of their publics. Within the United
Kingdom, the vaccinewas offered to: peoplewho fell into the usual sea-
sonal ﬂu vaccine at-risk groups as a result of having one of a range of
chronic illnesses; pregnant women; household contacts of immuno-
compromised people; front-line health and social care staff; and
children aged between 6months and 5 years (Hine, 2010).Whilst front-
line health and social care staff were offered the vaccine through their
occupational health departments at work, other groups were offered it
by the general practitioner [primary care practitioner], typically by let-
ter. Despite an extensive media campaign aimed at maximising uptake,practitioner].
s.michie@ucl.ac.uk (S. Michie),
(G.J. Rubin).
. This is an open access article undermost people who were offered the vaccine declined it. According to of-
ﬁcial ﬁgures, the uptake rate amongst targeted patient groups was
34.5% (Sethi and Pebody, 2010). This low uptake wasmirrored in coun-
tries world-wide, with a median coverage estimated at 21% (Brien and
Kwong, 2011). Understanding why uptake was low is important if we
are to improve vaccine coverage in the next pandemic.
Several factors may inﬂuence uptake. Recent systematic reviews of
pandemic vaccine uptake (Bish et al., 2011; Brien and Kwong, 2011)
have suggested that men, people from ethnic minorities and people
with a chronic illness are most likely to be vaccinated, whilst evidence
concerning the role of socioeconomic status and age is mixed. Within
England, however, higher age appears to be associated with uptake
(Biro, 2013). The psychological predictors of uptake that have been in-
vestigated broadly ﬁt with the framework of ProtectionMotivation The-
ory (Rogers, 1975). This theory speciﬁes that both ‘threat appraisals’ and
‘coping appraisals’ are important in determining health protective be-
haviour. In the context of a pandemic, threat appraisal relates to how
one perceives the risk associated with pandemic ﬂu. According to the
theory, behaviours designed to protect health are more likely to occurthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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have severe implications. Coping appraisal relates to how one perceives
the behaviours that are available to protect against the threat, with a
protective behaviour being more likely to be adopted if it is seen as ef-
fective (‘response efﬁcacy’ in the terminology of Protection Motivation
Theory), having few costs or side effects (‘response costs’) and being
something that the individual is capable of carrying out (‘self efﬁcacy’).
During the swine ﬂu pandemic, factors such as worry about the risk of
catching the illness (a concept which ﬁts broadly within the category
of threat appraisal (Boer and Seydel, 1996)), perceptions about the se-
verity of the pandemic and perceptions about the efﬁcacy and safety
of the vaccine have all been reported as predicting vaccine uptake
(Bish et al., 2011; Brien and Kwong, 2011). Factors that do not ﬁt neatly
within the Protection Motivation Theory may also have some explana-
tory power, including previous acceptance of the seasonal ﬂu vaccine
(Bish et al., 2011; Brien and Kwong, 2011) and trust in ofﬁcial agencies
(Siegrist and Zingg, 2014; Tucker Edmonds et al., 2011), a concept
which, in turn, incorporates perceptions of the competence and honesty
of those recommending vaccination.
A difﬁcultywithmany studies that have so far explored predictors of
pandemic vaccination is their reliance on self-reported intention to be
vaccinated as the outcome measure. Whilst intention to be vaccinated
is a good predictor of subsequent vaccination, the association is not per-
fect (Lehmann et al., 2014; Sheeran, 2002). Studies assessing predictors
of actual pandemic vaccination amongst the general public remain in
the minority (Bish et al., 2011; Brien and Kwong, 2011). To our knowl-
edge, none have been conducted in the UK which have examined
pandemic-related perceptions as predictors (Bish et al., 2011; Brien
and Kwong, 2011).
In this study, we conducted a secondary analysis of a dataset derived
from a series of national telephone surveys conducted in the UK during
the 2009/10 pandemic. These contained data on uptake of the swine ﬂu
vaccine amongst people who had been offered it by their primary care
physician. We tested whether uptake was associated with variables re-
lating to: demographic proﬁle; worry and believing that too much fuss
had been made about the pandemic (as components of threat apprais-
al); the perceived efﬁcacy of the vaccine (as a component of coping
appraisal); perceived preparedness of the government for a pandemic
and satisfaction with the amount of information being provided about
the pandemic (as components of trust); knowing people who had
been affected by swine ﬂu and having previously had the seasonal ﬂu
vaccine.Methods
The surveys
A full description of the survey methods has been provided elsewhere
(Rubin et al., 2015 ; Rubin et al., 2011; Rubin et al., 2010). In brief, during the
course of the pandemic, 39 telephone surveys were commissioned by the En-
glish Department of Health and run by the Ipsos MORI Social Research Institute.
Over time, survey questions were modiﬁed or removed and new questions
were added to meet the department's changing priorities in understanding
the reactions of the UK population to the ongoing pandemic. Sampling proce-
dures and eligibility criteria were identical across all of the surveys. Random
digit dialling and proportional quota sampling were used to ensure that the
sample for each survey was demographically representative of the UK popula-
tion. The quotas ensured that the number of participants within given groups
for age, sex, geographical region and social grade (a classiﬁcation system
based on the occupation of the chief income earner of a household)were equiv-
alent to the latest census statistics for the UK population. To be eligible for a sur-
vey, respondents had to be 16 years or over and speak English. Each surveywas
introduced to the participants as “a national survey on a variety of subjects.”
Other topics were only asked about after all inﬂuenza-related questions had
been covered. Response rates for each survey, calculated as the number of com-
pleted interviews divided by the total number of people spoken to, were in the
region of 9% to 10%.Distribution of the vaccine to general practices, and the time-lag involved in
contacting people who were eligible to receive it and making appointments for
them to be vaccinated, meant that the number of people vaccinated increased
steadily over time. A visual inspection of the percentage of respondents who re-
ported having received the H1N1 vaccination in each survey suggested that up-
take had begun to plateau by late December 2009.We assume that by this stage,
practical issues relating to the initiation of the vaccination campaign were no
longer themain barriers to uptake. To provide a larger sample size for our anal-
yses, we therefore pooled the data from the ﬁnal ﬁve surveys, spanning 28 De-
cember 2009 to 14 February 2010, for our analyses. In total, 5290 people
completed these surveys. All individual-level data for all of these participants
were available on a single spreadsheet, allowing this analysis to take place.
Vaccine uptake
All the participants were asked “have you been invited by your GP [general
practitioner]'s surgery to have the swine ﬂu vaccination, or not?” Possible an-
swers were “yes”, “no” or “don't know”. The participants were later informed
that “the swine ﬂu vaccination programme has started” and were asked to
“please tell mewhether you have had the swine ﬂu vaccine, or if not, how likely,
if at all, are you to take up a swine ﬂu vaccination if offered it?” Possible answers
were “I have already had the vaccination”, “very likely”, “fairly likely”, “not very
likely”, “not at all likely” and “don't know”. The participants who reported being
“not very” or “not at all likely” to have the vaccination were asked an open-
ended follow-up question: “what would you say is the main reason why you
would not be likely to take up a swine ﬂu vaccination if offered it?”
Demographic characteristics
Demographic data recorded for each participant included their age, sex, eth-
nicity, parental status and social grade (using the categorisation of ‘ABC1’
[broadly managerial or professional] vs ‘C2DE’ [broadly manual or casual
workers or unemployed on state beneﬁt]). (MRS, 2006). The participants were
asked “how is your health in general” (‘very good,’ ‘good,’ ‘fair,’ ‘poor,’ ‘very
poor’) and “do you have any long-standing illness, disability or inﬁrmity?”
Variables relating to threat appraisal, coping appraisal, seasonal ﬂu vaccination and
trust
In terms of variables that might map onto threat appraisal, the participants
in the surveys were asked “how worried, if at all, would you say you are now
about the possibility of personally catching swineﬂu?” The permitted responses
were “very worried,” “fairly worried,” “not very worried,” “not at all worried”
and “don't know”. The participants were also asked whether they agreed or
disagreed that “too much fuss is being made about the risk of swine ﬂu.”
With respect to coping appraisal, participants in the ﬁnal three surveyswere
asked to rate their opinions on the effectiveness of the swine ﬂu vaccination in
“reducing the risk of catching or passing on swine ﬂu”. Answers were recorded
on a scale of 1–10, with 1 being “no difference” and 10 being “it is vital”.
The participants in the ﬁnal four surveys were “have you had the regular
winter ﬂu jab in previous years, or not?”
The participants were asked whether anyone in the following groups had
had swine ﬂu: themselves; their children; or friends, colleagues or other family
members. In theﬁrst three surveys, theywere given ‘yes’ or ‘no’ options for each
category. For the ﬁnal two surveys, a ‘not sure’ option was also offered.
Two questions related to ofﬁcial responses to the pandemic that might re-
ﬂect trust. First, the participants were asked “how well prepared do you think
the Government is for a swine ﬂu pandemic,” with possible responses being
‘very,’ ‘fairly,’ ‘not very’ and ‘not at all.’ Second, the participants were asked
“how satisﬁed or dissatisﬁed are you with the amount of information available
to you on swine ﬂu, from any source,”with possible responses being ‘very satis-
ﬁed,’ ‘fairly satisﬁed,’ ‘neither satisﬁed nor dissatisﬁed,’ ‘fairly dissatisﬁed’ and
‘very dissatisﬁed.’
Analyses
We excluded the participants who had not been invited to have the swine
ﬂu vaccine by their GP. We also excluded the participants who had not yet ac-
cepted an invitation but who reported that they were ‘very’ or ‘fairly’ likely to
be vaccinated in the future, on the basis that these responses reﬂected inten-
tions rather than behaviour.
Table 1
Demographic characteristics of the participants and the association between these characteristics and vaccine uptake in the UK during 2009/10. Adjusted odds ratios were adjusted for all
other demographic variables: age, sex, ethnicity, parental status, social grade, general health status and presence of any long-standing inﬁrmity or illness.
Variable Levels Vaccinated
(n= 734)
Not vaccinated
(n= 396)
Odds ratio (95% conﬁdence
interval) for association with
vaccination status
Adjusted odds ratio
(95% conﬁdence interval)
for association with
vaccination status
Gender Male 322 (69.1%) 144 (30.9%) 1.37 (1.06 to 1.76) 1.34 (1.03 to 1.73)
Female 412 (62.0%) 252 (38.0%) Reference category Reference category
Age 16 to 24 19 (70.4%) 8 (29.6%) 1.20 (0.52 to 2.80) 1.44 (0.60 to 3.46)
25 to 34 26 (51.0%) 25 (49.0%) 0.53 (0.30 to 0.94) 0.73 (0.38 to 1.38)
35 to 54 167 (62.1%) 102 (37.9%) 0.83 (0.61 to 1.12) 0.96 (0.66 to 1.39)
55 to 64 164 (67.2%) 80 (32.8%) 1.04 (0.75 to 1.43) 1.02 (0.73 to 1.42)
65 or older 358 (66.4%) 181 (33.6%) Reference category Reference category
Social grade ABC1 333 (61.1%) 203 (37.9%) 0.79 (0.62 to 1.01) 0.86 (0.66 to 1.11)
C2DE 401 (67.5%) 193 (32.4%) Reference category Reference category
Ethnicity White 702 (64.6%) 384 (35.4%) 0.69 (0.35 to 1.35) 0.69 (0.34 to 1.39)
Other ethnicity 32 (72.7%) 12 (27.3%) Reference category Reference category
Parental status Has child 16 yrs. or under 97 (57.4%) 72 (42.6%) 0.69 (0.49 to 0.96) 0.83 (0.54 to 1.27)
Has older child or no children 637 (66.3%) 324 (33.7%) Reference category Reference category
General health status Poor or very poor 123 (73.7%) 44 (26.3%) 1.69 (1.26 to 2.28) 1.33 (0.96 to 1.84)
Fair 210 (71.4%) 84 (28.6%) 1.89 (1.30 to 2.76) 1.33 (0.87 to 2.02)
Very good or good 396 (59.6%) 268 (40.4%) Reference category Reference category
Presence of any long-standing
inﬁrmity or illness
Yes 450 (71.4%) 180 (28.6%) 1.90 (1.48 to 2.44) 1.60 (1.20 to 2.12)a
No 280 (56.8%) 213 (43.2%) Reference category Reference category
a. Re-analysis of this association excluding “general health status” as a covariate had little impact on the association (aOR 1.82, 95% CI (1.41, 2.34).
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vaccinated were initially coded by interviewers working for Ipsos MORI, using
38 categories that were pre-selected as potentially important by the Depart-
ment of Health in liaison with Ipsos MORI. To facilitate reporting, we grouped
some of these categories together.
For the quantitative questions, we counted responses of ‘don't know’, ‘un-
sure’, ‘not applicable’ or ‘neither agree nor disagree’ as missing data. Because
we had low sample sizes for several analyses, we combined some response op-
tions for some predictor variables (see Tables 1 and 2 for details). Binary logistic
regressionswere used to identify signiﬁcant predictors of vaccine uptake. A ﬁrst
set of regressions assessed the role of demographic variables in predicting the
likelihood of vaccine uptake, including after adjustment for all other demo-
graphic variables. A second set of regression models then tested the associationTable 2
Perceptions about swineﬂu, the vaccine and ofﬁcial responses to the outbreak, and their associa
age, sex, ethnicity, parental status, social grade, general health status and presence of any long
Variable Levels
Worry about the possibility of personally
catching swine ﬂu
Very or fairly worried
Not very or not at all worried
Too much fuss is being made about the
risk of swine ﬂu
Disagree
Agree
I have had swine ﬂu. Yes
No
My children have had swine ﬂu (analyses
restricted to parents).
Yes
No
Friends, colleagues or other family
members have had swine ﬂu
Yes
No
Perceived efﬁcacy of the vaccine Ratings of 1 (makes no difference at all)
to 10 (it is vital)
Have you had the seasonal ﬂu vaccine in
previous years?
Yes
No
How well prepared is the Government
for a swine ﬂu pandemic?
Very or fairly prepared
Not very or not at all prepared
Satisfaction with amount of information
available
Very or fairly satisﬁed
Very or fairly dissatisﬁedbetween the remaining predictor variables and vaccine uptake whilst adjusting
for demographic characteristics. Because not every question was used in every
survey, some of our analyses were based on a subset of the surveys.
Results
A total of 1320 participants had been invited by their GP to have the
swine ﬂu vaccination. Of these, 734 (55.6%) had received it. The remain-
ing 586 participants included 127 (9.6%)who reported being very likely
to be vaccinated, 50 (3.8%) who were fairly likely to be, 96 (7.3%) who
were not very likely, 300 (22.7%) who were not at all likely and 13
(1.0%) who did not know. Our analyses therefore focussed on the 734tionwith vaccine uptake in the UK during 2009/10. Adjusted odds ratios were adjusted for
-standing inﬁrmity or illness.
Vaccinated (n (%)
unless speciﬁed)
Not vaccinated (n (%)
unless speciﬁed)
Adjusted odds ratio
(95% conﬁdence interval)
for association with
vaccination status
64 (70.3%) 27 (29.7%) 1.18 (0.73 to 1.92)
666 (64.5%) 367 (35.5%) Reference category
275 (74.9%) 92 (25.1%) 2.12 (1.51 to 2.70)
376 (58.7%) 265 (41.3%) Reference category
19 (59.4%) 13 (40.6%) 0.84 (0.40 to 1.77)
715 (65.1%) 383 (34.9%) Reference category
9 (69.2%) 4 (30.8%) 1.54 (0.42 to 5.74)
88 (56.4%) 68 (43.6%) Reference category
167 (62.5%) 100 (37.5%) 0.95 (0.70 to 1.29)
567 (65.7%) 296 (34.3%) Reference category
Median: 10 (range 1 to 10,
n= 441)
Median: 5 (range 1 to 10,
n= 229)
1.67 (1.55 to 1.81)
505 (76.9%) 152 (23.1%) 6.77 (4.74 to 9.67)
83 (34.9%) 155 (65.1%) Reference category
553 (66.1%) 283 (33.9%) 1.34 (0.98 to 1.84)
146 (62.4%) 88 (37.6%) Reference category
639 (66.5%) 322 (33.5%) 1.63 (0.97 to 2.75)
42 (60.0%) 28 (40.0%) Reference category
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and were unlikely to be.
Qualitative data about uptake of the swine ﬂu vaccine
The top answers given by people as their main reason for not being
vaccinated were: I am concerned over how safe the vaccine is/it hasn't
been tested enough (101people out of 396 asked, 25.5%); I amgenerally
healthy and not overly concerned about catching swine ﬂu (n = 96,
24.2%); I don't like having vaccinations (n = 36, 9.1%); I don't know
enough about the vaccine (n = 22, 5.6%); and side effects/it makes
you ill/it causes ﬂu or a bad reaction (n= 17, 4.3%).
Association between demographic characteristics and likelihood of being
vaccinated
The demographic characteristics of the participants and the associa-
tions between these characteristics and vaccine uptake are shown in
Table 1. The participants were less likely to be vaccinated if: they were
female, had children aged 16 or under, were aged 25 to 34, had good
or very good health, and had no long-standing inﬁrmity or illness.
After adjusting for all other demographic variables, only the relation-
ships with sex and with the presence of a long-standing inﬁrmity or ill-
ness remained signiﬁcant. The inclusion of all demographic variables in
themodel resulted in a classiﬁcation accuracy of 64.9% and aNagelkerke
R2 of 0.05.
Association between threat appraisal, coping appraisal, seasonal ﬂu vacci-
nation, knowing someone who had contracted ﬂu and trust, with vaccine
uptake
Table 2 shows the results for the non-demographic predictor vari-
ables and their associations with vaccine uptake. The participants
were less likely to be vaccinated if they: felt that too much fuss was
beingmade about the risk of swine ﬂu, felt that the vaccinewas ineffec-
tive in preventing the spread of swine ﬂu, or had not had the seasonal
ﬂu vaccine in previous years. These associations remained signiﬁcant
after adjusting for demographic characteristics. The inclusion of all var-
iables in Table 2 in addition to all demographic variables in the model
improved the classiﬁcation accuracy to 84.5% and a Nagelkerke R2 of
0.78.
Discussion
According to our data, acceptance of the swine ﬂu vaccine amongst
adults offered it by their primary care practitionerwas 55.6%. This ﬁgure
is higher than the ofﬁcial ﬁgure of 34.5% which was generated by gath-
ering data directly from primary care practices (Sethi and Pebody,
2010). Overestimation of vaccine uptake appears to be a general prob-
lemwith telephone surveys (Brien and Kwong, 2011). Several explana-
tions may account for this, most particularly selection bias (with people
who are willing to take part in a survey being more compliant with
healthcare recommendations than those who decline to take part) and
recall bias (with participants who have been vaccinated being more
likely to remember receiving an invitation from their GP than those
who have not been vaccinated). Although substantial advantages exist
to using rapid turnaround telephone or web-based surveys to track be-
haviour and concernsduring amajor public health incident (Rubin et al.,
2008), caution is required in interpreting data derived from such
methods.
Despite this caveat, our data support the role of several demographic
variables in predicting vaccine uptake. Women, people with better self-
rated health, those without a long-lasting illness or inﬁrmity, those in
the 25 to 34 age bracket and those with young children were all less
likely to be vaccinated. Many of these ﬁndings have been reported pre-
viously (Bish et al., 2011; Brien and Kwong, 2011). Once all otherdemographic variables were adjusted for, however, only sex and the
presence of long-lasting illness or inﬁrmity remained signiﬁcant. Having
a chronic illnessmay increase perceptions of vulnerability to ﬂu. Several
chronic illnesses were also risk factors that determined whether some-
one would be offered the swine ﬂu vaccine. It is therefore logical that
the presence of a chronic illness could explain the association between
self-reported health, age or having young children (itself associated
with age) and vaccine uptake. The reasons why men are more likely
to accept the vaccine than women remain opaque, with previous re-
search having found no major differences between men and women
in terms of their motives for not accepting the swine ﬂu vaccination
(Velan, 2011). Others have hypothesised that, for seasonal ﬂu vaccine,
low uptake amongst women may result from healthcare provider bias,
a tendency for women to be more likely to see healthcare providers
who are less encouraging about the vaccine than men, or a tendency
for women to be less receptive to recommendations from healthcare
providers (Jiménez-García et al., 2010). Whether these factors are rele-
vant during a pandemic is unknown.
The importance of a person's health in determining vaccine uptake
also accords with the qualitative data for the open-ended question in-
cluded in the surveys. Here it was striking that only two factors
accounted for the majority of reasons given for not being vaccinated:
being ﬁt and healthy, and believing that the vaccine was unsafe. Yet
whilst other reasons were rarely spontaneously mentioned by the par-
ticipants, direct questioning did reveal the importance of additional fac-
tors. By far and away the strongest of these was a prior history of
vaccination against seasonal ﬂu. This is in line with multiple previous
studies (Bish et al., 2011; Brien and Kwong, 2011) and is likely to reﬂect
several underlying issues, including the role of habit, previous positive
experiences with vaccination, the absence of barriers to being vaccinat-
ed and similarities between the seasonal and swine ﬂu vaccine in terms
of perceptions about their efﬁcacy, concern about the effects of ﬂu and
trust in GPs.
As predicted by the Protection Motivation Theory (Rogers, 1975)
and in line with several previous studies (Bish et al., 2011; Brien and
Kwong, 2011), the perceptions about the efﬁcacy of the swine vaccine
strongly predicted uptake. The role of variables related to threat ap-
praisal was less clear. Earlier studies have suggested that anxiety or
worry about contracting swine ﬂu were associated with a higher likeli-
hood of being vaccinated (Bish et al., 2011; Brien and Kwong, 2011;
Rubin et al., 2011). In the present analyses, however, worry about the
possibility of catching swine ﬂu was not associated with vaccination.
This apparent discrepancy may be an artefact caused by the timing of
the questions in the surveys. If worrymotivates people to be vaccinated,
then a corollary is that being vaccinated should reduce worry removing
any statistical association. In contrast to worry, perceiving that too
much fuss had been made about the pandemic was associated with
not being vaccinated. Perceptions of “too much fuss” may be a useful
measure of threat appraisals in this context, as they reﬂect a
participant's assessment of how severe the pandemic is in general,
something that should not be affected by the act of receiving a
vaccination.
Although hypothesised by others as being relevant in predicting vac-
cination (Tucker Edmonds et al., 2011) and having been shown to pre-
dict other protective behaviours during the 2009/10 pandemic (Rubin
et al., 2009a), our trust-related variables showed no association with
vaccination status. These variables were not ideal as indicators of
trust, however, and caution is required in their interpretation. First,
the questions available to us tapped only two variables that make up
the broad construct of trust: the perceived competence of the
responding agency and their perceived openness. Other variables may
also be important, including the perceived priorities of the responding
agency and the consistency of their messages (Peters et al., 1997;
Rubin et al., 2012). Second, the questions were not speciﬁc to the vac-
cine, but rather to the general handling of the pandemic. Third, the
question addressing satisfaction with the amount of information
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government. And fourth, it is possible that trust in the government in
general is less important in predicting vaccination than trust in speciﬁc
responding agencies such as the NHS, one's primary health practitioner
or even the vaccinemanufacturers. Additional research on awider array
of trust-related variables is warranted.
Limitations
In addition to the issues raised above, several additional caveats
should be borne in mind when evaluating our results. First, the ques-
tions used in the original surveys were not always ideal for our pur-
poses, reﬂecting the pragmatic considerations at the time and the
speedwithwhich the surveys had to be put into the ﬁeld. Opportunities
were missed to assess additional constructs that have been speciﬁed by
theories of behaviour change (for example, self-efﬁcacy) and to test the
wording of questions (for example, the complex ‘worry’ item). Recent
work by our team in tandem with UK stakeholders has resulted in a
new set of survey items which will hopefully resolve some of these is-
sues in any future pandemic (Rubin et al., 2014).
Second, low sample sizes for some of our analyses resulted in wide
conﬁdence intervals and it is possible that as a result some important as-
sociations were not identiﬁed as signiﬁcant.
Third, a general problem with all research based on the 2009/10
pandemic is its generalisability to future pandemics. The relatively
mild nature of swine ﬂu may have led many members of the public to
equate it to seasonal ﬂu. This may not be the case in a more severe pan-
demic or one involving a different epidemiological pattern (for exam-
ple, where children are disproportionately affected). In such
situations, both the level of uptake of a vaccine and the determinants
of uptake may prove to be different.
Finally, because we analysed multiple predictor variables, there is a
possibility that some of our signiﬁcant ﬁndings are spurious, Type I
errors.
Conclusions
Uptake of the 2009/10 swineﬂu vaccine in theUKwas poor amongst
those offered it by their primary care physician. Low uptake was affect-
ed by perceptions that it was unnecessary for people who were ‘ﬁt and
healthy’ to be vaccinated, that the vaccine was unsafe or insufﬁciently
tested, that the vaccine was ineffective and that too much fuss was
being made about the pandemic. Tackling these perceptions may be
the key to encouraging uptake in future pandemics.
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